New Breast Cancer Drug May Benefit Younger Women, Too

WEDNESDAY, Dec. 6, 2017 -- Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found. The drug, called ribociclib (Kisqali), was approved by the U.S. Food and Drug...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news